| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |